» Articles » PMID: 32514269

Asiaticoside Inhibits TGF-β1-induced Mesothelial-mesenchymal Transition and Oxidative Stress Via the Nrf2/HO-1 Signaling Pathway in the Human Peritoneal Mesothelial Cell Line HMrSV5

Overview
Publisher Biomed Central
Date 2020 Jun 10
PMID 32514269
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Peritoneal fibrosis (PF) is a frequent complication caused by peritoneal dialysis (PD). Peritoneal mesothelial cells (PMCs), the first barrier of the peritoneum, play an important role in maintaining structure and function in the peritoneum during PD. Mesothelial-mesenchymal transition (MMT) and oxidative stress of PMCs are two key processes of PF.

Purpose: To elucidate the efficacy and possible mechanism of asiaticoside inhibition of MMT and ROS generation in TGF-β1-induced PF in human peritoneal mesothelial cells (HPMCs).

Methods: MMT and ROS generation of HPMCs were induced by TGF-β1. To explain the anti-MMT and antioxidant role of asiaticoside, varied doses of asiaticoside, oxygen radical scavenger (NAC), TGF-β receptor kinase inhibitor (LY2109761) and Nrf2 inhibitor (ML385) were used separately. Immunoblots were used to detect the expression of signaling associated proteins. DCFH-DA was used to detect the generation of ROS. Transwell migration assay and wound healing assay were used to verify the capacity of asiaticoside to inhibit MMT. Immunofluorescence assay was performed to observe the subcellular translocation of Nrf2 and expression of HO-1.

Results: Asiaticoside inhibited TGF-β1-induced MMT and suppressed Smad signaling in a dose-dependent manner. Migration and invasion activities of HPMCs were decreased by asiaticoside. Asiaticoside decreased TGF-β1-induced ROS, especially in a high dose (150 μM) for 6 h. Furthermore, ML385 partly abolished the inhibitory effect of asiaticoside on MMT, ROS and p-Smad2/3.

Conclusions: Asiaticoside inhibited the TGF-β1-induced MMT and ROS via Nrf2 activation, thus protecting the peritoneal membrane and preventing PF.

Citing Articles

Yunpiqiangshen gel improves quality of life in dialysis patients.

Manshu Y, Chunchun J, Min Y, Jianwu H, Yan J, Min H J Tradit Chin Med. 2025; 45(1):123-131.

PMID: 39957166 PMC: 11764941. DOI: 10.19852/j.cnki.jtcm.2025.01.011.


Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosis.

Meng X, Sheng L, You Y, Dai H, Yu M, Wang F Front Pharmacol. 2025; 16:1515038.

PMID: 39917615 PMC: 11799242. DOI: 10.3389/fphar.2025.1515038.


Asiaticoside improves diabetic nephropathy by reducing inflammation, oxidative stress, and fibrosis: An and study.

Zhuang L, Zhang R, Jin G, Pei X, Wang Q, Ge X World J Diabetes. 2024; 15(10):2111-2122.

PMID: 39493557 PMC: 11525727. DOI: 10.4239/wjd.v15.i10.2111.


Peritoneal dialysis promotes microbial-driven biosynthesis pathways of sesquiterpenes and triterpenes compounds in end-stage renal disease patients.

Wang X, Yao S, Yang X, Li Y, Yu Z, Huang J BMC Microbiol. 2024; 24(1):377.

PMID: 39342083 PMC: 11437912. DOI: 10.1186/s12866-024-03539-3.


Astragalus membranaceus and its monomers treat peritoneal fibrosis and related muscle atrophy through the AR/TGF-β1 pathway.

Sheng L, Sun J, Huang L, Yu M, Meng X, Shan Y Front Pharmacol. 2024; 15:1418485.

PMID: 39239655 PMC: 11374727. DOI: 10.3389/fphar.2024.1418485.


References
1.
Oh C, Kim J, Choi Y, Kim H, Jeong J, Bae K . Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling. PLoS One. 2012; 7(10):e45870. PMC: 3466265. DOI: 10.1371/journal.pone.0045870. View

2.
Krediet R, Struijk D . Peritoneal changes in patients on long-term peritoneal dialysis. Nat Rev Nephrol. 2013; 9(7):419-29. DOI: 10.1038/nrneph.2013.99. View

3.
Jeong B, Park S, Cho S, Yu S, Lee H, Park C . TGF-β-mediated NADPH oxidase 4-dependent oxidative stress promotes colistin-induced acute kidney injury. J Antimicrob Chemother. 2018; 73(4):962-972. DOI: 10.1093/jac/dkx479. View

4.
Liakopoulos V, Roumeliotis S, Gorny X, Eleftheriadis T, Mertens P . Oxidative Stress in Patients Undergoing Peritoneal Dialysis: A Current Review of the Literature. Oxid Med Cell Longev. 2018; 2017:3494867. PMC: 5892210. DOI: 10.1155/2017/3494867. View

5.
Nguyen T, Nioi P, Pickett C . The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem. 2009; 284(20):13291-5. PMC: 2679427. DOI: 10.1074/jbc.R900010200. View